Association analysis of the GSK-3β T-50C gene polymorphism with schizophrenia and bipolar disorder

Neuropsychobiology

Volumn 53, Issue 1, 2006, Pages 51-56

  Szczepankiewicz, Aleksandra ^a   Skibinska, Maria ^a   Hauser, Joanna ^a   Slopien, Agnieszka ^a   Leszczynska Rodziewicz, Anna ^a   Kapelski, Paweł ^a   Dmitrzak Weglarz, Monika ^a   Czerski, Piotr M ^a   Rybakowski, Janusz K ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Bipolar disorder; Glycogen synthase kinase 3 gene polymorphism; Schizophrenia

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA;

ADULT; ALLELE; ARTICLE; BIPOLAR DISORDER; CONSENSUS; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSYCHIATRIST; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHIZOPHRENIA;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; BIPOLAR DISORDER; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MALE; MIDDLE AGED; POLAND; POLYMORPHISM, SINGLE NUCLEOTIDE; REFERENCE VALUES; SCHIZOPHRENIA; SEX FACTORS; STATISTICS, NONPARAMETRIC;

EID: 32844468372     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090704     Document Type: Article

References (27)

1. Arnold SE, Rioux L: Challenges, status, and opportunities for studying developmental neuropathology in adult schizophrenia. Schizophr Bull 2001;27:395-416.
2. Cohen P: The role of protein phosphorylation in the hormonal control of enzyme activity. Eur J Biochem 1985;151:439-448.
3. Leroy K, Brion JP: Developmental expression and localization of glycogen synthase kinase-3β in rat brain. J Chem Neuroanat 1999;16:279-293.
4. Pei JJ, Braak E, Braak H, Grundke-Iqbal I, Iqbal K, Winblad B, Cowburn RF: Distribution of active glycogen synthase kinase 3β (GSK-3β) in brains staged for Alzheimer disease neurofibrillary changes. J Neuropathol Exp Neurol 1999;58:1010-1019.
5. Woodgett JR: Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J 1990;9:2431-2438.
6. Yu JS, Yang SD: Immunological and biochemical study on tissue and subcellular distributions of protein kinase FA (an activating factor of ATP-Mg-dependent protein phosphatase): a simplified and efficient procedure for high quantity purification from brain. J Protein Chem 1993;12:667-676.
7. Woodgett JR: A common denominator linking glycogen metabolism, nuclear oncogenes and development. Trends Biochem Sci 1991;16:177-181.
8. Shaw PC, Davies AF, Lau KF, Garcia-Barcelo M, Waye MM, Lovestone S, Miller CC, Anderton BH: Isolation and chromosomal mapping of human glycogen synthase kinase-3α and -3β encoding genes. Genome 1998;41:720-727.
9. Srivastava AK, Pandey SK: Potential mechanism(s) involved in the regulation of glycogen synthesis by insulin. Mol Cell Biochem 1998;182:135-141.
10. He X, Saint-Jeannet JP, Woodgett JR, Varmus HE and Dawid IB: Glycogen synthase kinase-3 and dorsoventral patterning in Xenopus embryos. Nature 1995;374:617-622.
11. Kozlovsky N, Belmaker RH, Agam G: Low GSK-3β immunoreactivity in postmortem frontal cortex of schizophrenic patients. Am J Psychiatry 2000;157:831-833.
12. Beasley C, Cotter D, Khan N, Pollard C, Sheppard P, Varndell I, Lovestone S, Anderton B, Everall I: Glycogen synthase kinase-3β immunoreactivity is reduced in the prefrontal cortex in schizophrenia. Neurosci Lett 2001;302:117-120.
13. Kozlovsky N, Belmaker RH, Agam G: Low GSK-3 activity in frontal cortex of schizophrenic patients. Schizophr Res 2001;52:101-105.
14. Agam G, Shaltiel G, Kozlovsky N, Shimon H, Belmaker RH: Lithium inhibitable enzymes in postmortem brain of bipolar patients. J Psychiatr Res 2003;37:433-442.
15. Li X, Bijur GN, Jope RS: Glycogen synthase kinase-3β, mood stabilizers, and neuroprotection. Bipolar Disord 2002;4:137-144.
16. O'Brien WT, Harper AD, Jove F, Woodgett JR, Maretto S, Piccolo S, Klein PS: Glycogen synthase kinase-3β haploinsufficiency mimics the behavioral and molecular effects of lithium. J Neurosci 2004;24:6791-6798.
17. Gould TD, Chen G, Manji HK: In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3. Neuropsychopharmacology 2004;29:32-38.
18. Iwahana E, Akiyama M, Miyakawa K, Uchida A, Kasahara J, Fukunaga K, Hamada T, Shibata S: Effect of lithium on the circadian rhythms of locomotor activity and glycogen synthase kinase-3 protein expression in the mouse suprachiasmatic nuclei. Eur J Neurosci 2004;19:2281-2287.
19. Gould TD, Zarate CA, Manji HK: Glycogen synthase kinase-3: a target for novel bipolar disorder treatments. J Clin Psychiatry 2004;65:10-21.
20. Russ C, Lovestone S, Powell JF: Identification of sequence variants and analysis of the role of the glycogen synthase kinase 3β gene and promoter in late onset Alzheimer's disease. Mol Psychiatry 2001;6:320-324.
21. Lau KF, Miller CC, Anderton BH, Shaw PC: Molecular cloning and characterization of the human glycogen synthase kinase-3β promoter. Genomics 1999;60:121-128.
22. n repeat GSK-3β gene polymorphisms with schizophrenia. Neuropsychobiology 2004;50:16-20.
23. Benedetti F, Bernasconi A, Lorenzi C, Pontiggia A, Serretti A, Colombo C, Smeraldi E: A single nucleotide polymorphism in glycogen synthase kinase 3β promoter gene influences onset of illness in patients affected by bipolar disorder. Neurosci Lett 2004;355:37-40.
24. First MB, Spitzer RL, Gibbon M, Williams J: Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). Washington, American Psychiatric Press, 1996.
25. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
26. Schulze TG, Muller DJ, Krauss H, Scherk H, Ohlraun S, Syagailo YV, Windemuth C, Neidt H, Grassle M, Papassotiropoulos A, Heun R, Nothen MM, Maier W, Lesch KP, Rietschel M: Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder. Am J Med Genet 2000;96:801-803.
27. Liu W, Gu N, Feng G, Zhang J, Li S, Bai S, Shen T, Clair DS, He L: Association of VNTR region of the human serotonin transporter gene with bipolar disorder among the Han Chinese. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 1998; 15:345-348.